Focused Ultrasound in Septic Shock Patients
NCT01920776 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2013-08-12
Summary
The investigators hypothesize that lung ultrasound and echocardiography will benefit the septic shock patients by making the treatment more precisely and rapidly. Septic shock patients from multicenter will be enrolled in the study. They will be randomly divided into two groups. The routine treatment group will receive routine treatment according to the SSC guideline. The study group will receive additional ultrasound examination, which will decide the improvement of therapy. Therapy change based on ultrasound results and the prognosis will be recorded.
Conditions
- Septic Shock
Interventions
- OTHER
-
ultrasound examination
- OTHER
-
Ultrasound group
Ultrasound group will receive ultrasound examination at least once a day, the results will be noted to the attending who is in charge of the treatment.
Sponsors & Collaborators
-
Peking Union Medical College Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2014-07-31
Countries
- China
Study Locations
More Related Trials
-
Lung Ultrasound-guided Fluid Resuscitation in Neonatal Septic Shock
NCT06144463 ·Status: COMPLETED ·Phase: NA
-
POCUS-Guided Esmolol in Septic Shock: A Pilot RCT
NCT07313605 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
The Randomized Controlled Trial of Inferior Vena Cava Ultrasound-guided Fluid Management in Septic Shock Resuscitation
NCT03020407 ·Status: COMPLETED ·Phase: NA
-
Impact of an Echographic Algorithm on Hemodynamic Optimization in the First 4 Days of Septic Shock Management
NCT06043505 ·Status: RECRUITING ·Phase: NA
-
Endotoxin in Gram-negative Septic Shock
NCT01602354 ·Status: UNKNOWN
-
Septic Shock Management Guided by Ultrasound: SEPTICUS Trial
NCT04728529 ·Status: UNKNOWN ·Phase: NA
-
Methylene Blue for the Treatment of Septic Shock
NCT06532240 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of CUGP Fluid Management in Patients With Sepsis or Septic Shock
NCT06879249 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Impaired Microcirculation During Septic Shock With Contrast Enhanced Ultrasound
NCT02277977 ·Status: WITHDRAWN ·Phase: NA
-
Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections
NCT00934011 ·Status: COMPLETED ·Phase: NA
-
Cytokine Response in Septic Shock
NCT01770457 ·Status: UNKNOWN
-
Effects of Terlipressin on Renal Perfusion in Patients With Septic Shock
NCT04948372 ·Status: COMPLETED ·Phase: NA
-
Early Goal Directed Sedation on Microcirculation in Septic Shock
NCT02612363 ·Status: UNKNOWN ·Phase: PHASE4
-
Critical Closing Pressure and PCO₂ Gap in Fluid Resuscitation for Septic Shock
NCT07043192 ·Status: ACTIVE_NOT_RECRUITING
-
Role of Early Point of Care Ultrasound in Management of Sepsis in Emergency Department
NCT05849194 ·Status: COMPLETED ·Phase: NA
-
Pilot Study: Echocardiographic and Hemodynamic Effects of Esmolol in Septic Shock Patients
NCT02842983 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
VTE Incidence in Severe Sepsis and Septic Shock
NCT02353910 ·Status: COMPLETED
-
Ultrasound Optimization of Initial Fluid Challenge in Sepsis
NCT04028102 ·Status: UNKNOWN
-
Clinical Research on Shenfu Injection in Septic Patients
NCT06157320 ·Status: RECRUITING ·Phase: NA
-
Plasma and Lung Tissue Concentrations of Linezolid in Septic Shock Patients
NCT03308227 ·Status: UNKNOWN
-
Therapeutic Plasma Exchange in Septic Shock: A Pilot Study
NCT05093075 ·Status: RECRUITING ·Phase: PHASE2
-
Guiding Fluid Resuscitation in Septic Shock: Ultrasound vs. Noninvasive Cardiac Output Monitoring
NCT07162857 ·Status: COMPLETED ·Phase: NA
-
Immune Function Monitoring and Immunotherapy in Sepsis
NCT04903405 ·Status: UNKNOWN
-
Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa
NCT01841190 ·Status: UNKNOWN
-
A Prediction Model of 28-day Mortality in Septic Shock
NCT04915625 ·Status: UNKNOWN